$1.16
Price
$49M
Market Cap
—
P/E Ratio
-2.8
Forward P/E
$-1.61
EPS (TTM)
—
Dividend Yield
$8M
Cash
—
Total Debt
42M
Shares Out
$0.73
$2.45
52-Week Range
Institutional Ownership of RA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for RA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2020-Q2 | |||||
| SELL | EXIT | — | — | — | |
| 2020-Q1 | |||||
| BUY | NEW | 42.0K | $2M | — | |
Insider Trading for RA PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $0
0
Buys
0
Sells
+0
Net
3
Grants
Largest
$86K
Aminov
$30K
Shekhat
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 01, 2025 | Denil Nanji Shekhat | Director | GRANT | 22.4K | $1.35 | $30K |
| Oct 01, 2025 | Erez Aminov | Chief Executive Officer | GRANT | 2.69M | — | — |
| Aug 29, 2025 | Erez Aminov | Chief Executive Officer | GRANT | 62.5K | $1.37 | $86K |